HBOC alleviated tumour hypoxia during radiotherapy more intensely in large solid tumours than regular ones

References

• Lang JY. Retrospect, thinking and prospect of radiotherapy in China in the past 30 years. Cancer Prev Treat. 2017;30(1):1–4 + 6.
   Google Scholar
• Cruz FD, Matushansky I. Solid tumor differentiation therapy – is it possible? Oncotarget. 2012;3(5):559–567. doi:10.18632/oncotarget.512.
   PubMedGoogle Scholar
• Wang H, Jiang H, Van De Gucht M, et al. Hypoxic radioresistance: can ROS be the key to overcome it? Cancers. 2019;11(1):112. doi:10.3390/cancers11010112.
   PubMed Web of Science ®Google Scholar
• Marie-Egyptienne DT, Lohse I, Hill RP. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia. Cancer Lett. 2013;341(1):63–72. doi:10.1016/j.canlet.2012.11.019.
   PubMed Web of Science ®Google Scholar
• Barker HE, Paget JT, Khan AA, et al. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15(7):409–425. doi:10.1038/nrc3958.
   PubMed Web of Science ®Google Scholar
• Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004;4(6):437–447. doi:10.1038/nrc1367.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Hypoxic radiosensitization: adored and ignored. J Clin Oncol. 2007;25(26):4066–4074. doi:10.1200/JCO.2007.12.7878.
   PubMed Web of Science ®Google Scholar
• Yuan M, Liang S, Zhou Y, et al. A robust oxygen-carrying hemoglobin-based natural sonosensitizer for sonodynamic cancer therapy. Nano Lett. 2021;21(14):6042–6050. doi:10.1021/acs.nanolett.1c01220.
   PubMed Web of Science ®Google Scholar
• Feng J, Yu W, Xu Z, et al. An intelligent ZIF-8-gated polydopamine nanoplatform for in vivo cooperatively enhanced combination phototherapy. Chem Sci. 2020;11(6):1649–1656. doi:10.1039/c9sc06337d.
   PubMed Web of Science ®Google Scholar
• Teicher BA, Herman TS, Hopkins RE, et al. Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents. J Cancer Res Clin Oncol. 1992;118(2):123–128. doi:10.1007/BF01187500.
   PubMed Web of Science ®Google Scholar
• Jahr JS, Guinn NR, Lowery DR, et al. Blood substitutes and oxygen therapeutics: a review. Anesth Analg. 2021;132(1):119–129. doi:10.1213/ANE.0000000000003957.
   PubMed Web of Science ®Google Scholar
• Standl T. Haemoglobin-based erythrocyte transfusion substitutes. Expert Opin Biol Ther. 2001;1(5):831–843. doi:10.1517/14712598.1.5.831.
   PubMed Web of Science ®Google Scholar
• Raabe A, Gottschalk A, Hommel M, et al. No effect of the hemoglobin solution HBOC-201 on the response of the rat R1H tumor to fractionated irradiation. Strahlenther Onkol. 2005;181(11):730–737. doi:10.1007/s00066-005-1418-3.
   PubMed Web of Science ®Google Scholar
• Lee NP, Chan KT, Choi MY, et al. Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts. Cancer Chemother Pharmacol. 2015;76(6):1199–1207. doi:10.1007/s00280-015-2897-2.
   PubMed Web of Science ®Google Scholar
• Belcher DA, Lucas A, Cabrales P, et al. Tumor vascular status controls oxygen delivery facilitated by infused polymerized hemoglobins with varying oxygen affinity. PLOS Comput Biol. 2020;16(8):e1008157. doi:10.1371/journal.pcbi.1008157.
   PubMed Web of Science ®Google Scholar
• Qi X, Wong BL, Lau SH, et al. A hemoglobin-based oxygen carrier sensitized cisplatin based chemotherapy in hepatocellular carcinoma. Oncotarget. 2017;8(49):85311–85325. doi:10.18632/oncotarget.19672.
   PubMedGoogle Scholar
• Gao YQ, Zhu KH, Xv YC, et al. Preliminary study on enhancing chemosensitivity of subcutaneous xenograft of breast cancer in nude mice with polymeric human umbilical cord hemoglobin oxygen carrier. Chinese J Blood Transf. 2022;35(05):475–479.
   Google Scholar
• Dong DC, Gao YQ, Wang H, et al. Preliminary experiment on enhancing the therapeutic effect of lenvatinib on subcutaneous xenograft of liver cancer in nude mice using aggregated human umbilical cord blood hemoglobin oxygen carriers. Chinese J Blood Transf. 2021;34(5):456–460.
   Google Scholar
• Belcher DA, Ju JA, Baek JH, et al. The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: a theoretical and experimental study. PLoS One. 2018;13(2):e0191275. doi:10.1371/journal.pone.0191275.
   PubMed Web of Science ®Google Scholar
• Niemoeller OM, Belka C. Radiotherapy and TRAIL for cancer therapy. Cancer Lett. 2013;332(2):184–193. doi:10.1016/j.canlet.2011.07.003.
   PubMed Web of Science ®Google Scholar
• Chithrani DB, Jelveh S, Jalali F, et al. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res. 2010;173(6):719–728. doi:10.1667/RR1984.1.
   PubMed Web of Science ®Google Scholar
• Huo D, Liu S, Zhang C, et al. Hypoxia-targeting, tumor microenvironment responsive nanocluster bomb for radical-enhanced radiotherapy. ACS Nano. 2017;11(10):10159–10174. doi:10.1021/acsnano.7b04737.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer. 2008;8(6):425–437. doi:10.1038/nrc2397.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Mortensen LS, Petersen JB, et al. Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol. 2012;9(12):674–687. doi:10.1038/nrclinonc.2012.171.
   PubMed Web of Science ®Google Scholar
• Lucas A, Belcher DA, Munoz C, et al. Polymerized human hemoglobin increases the effectiveness of cisplatin-based chemotherapy in non-small cell lung cancer. Oncotarget. 2020;11(42):3770–3781. doi:10.18632/oncotarget.27776.
   PubMedGoogle Scholar
• Heldin C-H, Rubin K, Pietras K, et al. High interstitial fluid pressure-an obstacle in cancer therapy. Nat Rev Cancer. 2004;4(10):806–813. doi:10.1038/nrc1456.
   PubMed Web of Science ®Google Scholar
• Wang X, Wu M, Li H, et al. Enhancing penetration ability of semiconducting polymer nanoparticles for sonodynamic therapy of large solid tumor. Adv Sci. 2022;9(6):2104125. doi:10.1002/advs.202104125.
   Web of Science ®Google Scholar
• Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26(2):225–239. doi:10.1007/s10555-007-9055-1.
   PubMed Web of Science ®Google Scholar
• Martin AR, Ronco C, Demange L, et al. Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories. Medchemcomm. 2017;8(1):21–52. doi:10.1039/c6md00432f.
   PubMed Web of Science ®Google Scholar
• Tsai YP, Wu KJ. Hypoxia-regulated target genes implicated in tumor metastasis. J Biomed Sci. 2012;19(1):102. doi:10.1186/1423-0127-19-102.
   PubMedGoogle Scholar
• Zhu M, Yin F, Fan X, et al. Decreased TIP30 promotes snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma. Oncogene. 2015;34(11):1420–1431. doi:10.1038/onc.2014.73.
   PubMed Web of Science ®Google Scholar
• Cserni G, Vörös A, Liepniece-Karele I, et al. Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values. Breast. 2014;23(3):59–63.
   Web of Science ®Google Scholar
• Tiburcio PD, Choi H, Huang LE. Complex role of HIF in cancer: the known, the unknown, and the unexpected. Hypoxia. 2014;2:59–70.
   PubMedGoogle Scholar
• Nowak A, Grzegrzolka J, Paprocka M, et al. Nestin-positive microvessel density is an independent prognostic factor in breast cancer. Int J Oncol. 2017;51(2):668–676. doi:10.3892/ijo.2017.4057.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010;29(5):625–634. doi:10.1038/onc.2009.441.
   PubMed Web of Science ®Google Scholar
• Yang J, Li W, Luo L, et al. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance. Biomaterials. 2018;182:145–156. doi:10.1016/j.biomaterials.2018.08.004.
   PubMed Web of Science ®Google Scholar
• Tao J, Yang G, Zhou W, et al. Targeting hypoxic tumor microenvironment in pancreatic cancer. J Hematol Oncol. 2021;14(1):14. doi:10.1186/s13045-020-01030-w.
   PubMed Web of Science ®Google Scholar
• Sun Y. Tumor microenvironment and cancer therapy resistance. Cancer Lett. 2016;380(1):205–215. doi:10.1016/j.canlet.2015.07.044.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Izumi Y, Horinouchi H, et al. Systemic administration of hemoglobin vesicle elevates tumor tissue oxygen tension and modifies tumor response to irradiation. J Surg Res. 2009;151(1):48–54. doi:10.1016/j.jss.2007.12.770.
   PubMed Web of Science ®Google Scholar
• Menegakis A, Klompmaker R, Vennin C, et al. Resistance of hypoxic cells to ionizing radiation is mediated in part via hypoxia-induced quiescence. Cells. 2021;10(3):610. doi:10.3390/cells10030610.
   PubMed Web of Science ®Google Scholar
• Hawley L. Principles of radiotherapy. Br J Hosp Med. 2013;74(11):C166–C169. doi:10.12968/hmed.2013.74.sup11.c166.
   Web of Science ®Google Scholar